Navigation Links
Packard Children's Hospital, Foundation Provide Financial Support for School Nurses in San Jose
Date:11/5/2007

g a health center at every school can initially seem prohibitive, said David Alexander, MD, president and CEO of the Lucile Packard Foundation for Children's Health.

"With this project, we hope to demonstrate that a network of school nurses who are formally linked to a clinic serving multiple schools is a cost-effective model for getting children the care they need to succeed in school," Alexander said.

Almost 5,000 students in the San Jose Unified District -- 18 percent -- are diagnosed with chronic health problems. Nurses typically are responsible for three or four schools, and the increasing caseloads of chronic medical problems have reduced time for routine health screenings and health education.

Children with chronic conditions are absent more frequently, which not only creates additional learning challenges for the student but also reduces state reimbursement to schools, which is based on average daily attendance.

The project, which the hospital and the foundation will fund equally, will maintain the nurses for five years in four schools: Hoover and Burnett Academy middle schools, and Empire Gardens and Anne Darling elementary schools. All currently are covered by part-time nurses. The schools were chosen because they have a high percentage of students living in poverty; substantial enrollments of children who do not have access to regular health care; and proximity to the School Health Clinics at San Jose High Academy and Washington Elementary School. The clinics can provide services from physicians, physician assistants, nurses, a dietitian, and a health educator.

Researchers from the Stanford University School of Medicine will evaluate the project, analyzing measures such as access to ongoing health services, management of chronic problems and school attendance.

"As the children's hospital for Santa Clara County, we currently see many children from San Jose," said Christopher Dawes, president and CEO at Packard Children's
'/>"/>

SOURCE Lucile Packard Children's Hospital
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Packard Childrens Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home
2. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
3. SIEMENS, AlliedBarton, Methodist Hospital, and Family Planning Council Win Human Resources Department of the Year Awards
4. Survival of newborns with abdominal holes differs according to hospital, Hopkins research shows
5. National Patient Safety Foundation Partners with Vocera Communications
6. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
7. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
8. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
9. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
10. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
11. The Tug McGraw Foundation Announces 2007 Fundraising Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...way to fight leukemia might be to knock out a spec..., a new study shows// . The findings suggest tha...ght on its own be an effective therapy. But such... with several existing drugs might also offer an e...
...drink heavily during the college days has an incre..., reports researchers// at the American Heart Asso...s. In a small study, Minnesota researchers found...drank heavily had higher levels of C-reactive prot...
...ave identified a subgroup of hard-to-treat breast ...n, rarely used in the treatment of breast tumors. ... this sensitivity, which may help identify patient.... The findings will be tested in a clinical trial ...
...ell-based therapeutic vaccine for pancreatic cance...rom progressing in a handful of patients three yea...ng evidence that the vaccine can trigger a patient...er and offer new insights into how the vaccine cou...
Other Medicine News:Health News:Knocking Out Survival Protein Could Fight Leukemia 2Health News:Alcohol Abuse During College Days Leads to Heart Disease in Later Life 2Health News:Alcohol Abuse During College Days Leads to Heart Disease in Later Life 3Health News:Researchers Have Identified Subgroup Sensitive to the Drug Cisplatin 2Health News:Vaccine for Pancreatic Cancer Halts Progression of Disease in Some Patients 2
(Date:9/4/2008)...ctivity and favorable safety ...Newswire-FirstCall/ -- Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...s diseases, today announced that it has completed ...n-nucleoside reverse,transcriptase inhibitor (NNRT...
(Date:9/3/2008)...ll/ -- Simcere,Pharmaceutical Group (NYSE: SCR ),...neric pharmaceuticals and manufacturer of the pate...as Endostar) in China,announced the interim resul...st of the SFDA, Simcere initiated a Phase IV clini...peutic efficacy of Endu, a modified,version of rec...
(Date:9/3/2008)...Panacea Pharmaceuticals,Inc. today announced the ...antibodies against human aspartyl (asparaginyl) be...biomarker and therapeutic target. These antibodies...setts Institute of,Technology (MIT) and Panacea ha...evelopment of human cancer diagnostics and therape...
(Date:9/3/2008)...udy in Subjects with ALS, RICHMOND, Calif., Sept....Inc. (Nasdaq: SGMO ) announced today that it has ...aluate its drug, SB-509, in subjects,with ALS, a p...which there,are limited treatment options and no c...rmulation of a plasmid,encoding a zinc finger DNA-...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5After drought ponds keep up with the Joneses 808 1After drought ponds keep up with the Joneses 808 2After drought ponds keep up with the Joneses 808 3Studies Examine Life After Weight Loss Surgery 3715 1Studies Examine Life After Weight Loss Surgery 3715 2Studies Examine Life After Weight Loss Surgery 3715 3Studies Examine Life After Weight Loss Surgery 3715 4Baxter International Third Quarter 2007 Financial Results Conference Call 3712 1James B Hawkins Appointed to IRIDEX Board of Directors 3709 1James B Hawkins Appointed to IRIDEX Board of Directors 3709 2James B Hawkins Appointed to IRIDEX Board of Directors 3709 3
...rstCall/ -- Vanda,Pharmaceuticals Inc. announced t... Sleep Disorders and Research Center in Detroit, M...se III clinical,trial results for VEC-162, Vanda,s... SLEEP 2007, the 21st annual meeting of the,Associ...anda presentation will take place at the Conventio...
...ation during the,early post-operative period compa...ction in nausea in the female,patient population c... - CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambr...ditional data from post-hoc analysis of the recent...ronide) in over 500 patients,with post-operative p...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
Elongated Loop, Slightly Curved; in Stainless Steel.
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM
AXIOM Artis TA is part of the AXIOM family, which introduces dynamic and efficient workflow into the clinical angiography, card- angiography, and neuroradiology procedures. On the clinical, technical
AXIOM Artis FA is a universal floor-mounted angiographic C-arm system whose flexible system architecture is ideal for vascular and non-vascular diagnostics and interventions. It provides complete erg
Medicine Products: